Zybcm: An effective treatment for nicotine addiction

Hospital Medicine

Volumn 61, Issue 11, 2000, Pages 785-788

  Steele, Chris ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DOPAMINE UPTAKE INHIBITOR;

ADOLESCENT; ADULT; AGED; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; MIDDLE AGED; REVIEW; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BUPROPION; COST-BENEFIT ANALYSIS; DOPAMINE UPTAKE INHIBITORS; HUMANS; MIDDLE AGED; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 0034326907     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2000.61.11.1923     Document Type: Article

References (15)

1. American Psychiatrie Association (1987) Diagnostic und Statistical Manual of Mental Disorders. 3rd edn. American Psychiatric Association, Washington
2. Arnstcn JH (1996) Treatment of nicotine dependence in the primary care setting. Prim Psychiatry 3: 27-30
3. Benowitz NL (1999) Nicotine addiction. Primarr Care 26: 611-31
4. Britten J (2000) Nicotine Addiction in Britain. Royal College of Physicians Tobacco Advisory Group. Royal College of Physicians, London
5. Browning DC, Hogue SL. Orme ME, Boler AF (2000) Cost effectiveness of Zyhan in the United Kingdom, Abstract. llth World Conference on Tobacco or Health (WCTH) Chicago, USA
6. Department of Health (1998) Smoking Kills: a While Paper on Tobacco. The Stationary Office, London
7. Ferry LH (1999) Non-nicotine therapy for smoking cessation. Primarv Care in Office Practice 26: 653-69
8. Hughes JR. H'iggins ST. Hatsukami D (1990) Effects of abstinence from tobacco. A critical review. In: Kozllowski LT. Annis H. Cappell HD et al, eds. Research Advances in Druif and Alcohol Problems. Plenum Press, New York: 317 -98
9. Hurt RD (1997) Comparison of sustained release bupropion and placebo for smoking cessation. ,V Engl J Meil 337: 1195-202
10. Jorenby DE, Leischow SJ, Nides MA (1999) A controlled trial of sustained - release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340: 685-91
11. Parrott S, Godfrey C, Raw M, West R, McNeill A (1998) Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Thorax 53(Suppl 5, part 2): S1-19
12. Raw M, McNeill A, West R (1998) Smoking cessation guidelines and their cost effectiveness. Thorax 53(Suppl 5, Part 1): S3-S7
13. Sachs DPL (1991 (Advances in smoking cessation treatment. In: Simmons DH, ed. Current Pidmonology. Year book medical publishers. Chicago: 139-98
14. Thompson GH, Hunter DA (1998) Nicotine replacement therapy. Ann Phannacother 32: 1067-75
15. World Health Organization (1992) International Statistical Classification of Diseasese and related Health Problems. 10th revision. World Health Organization, Geneva